11:41 AM EST - Protox Therapeutics Inc. : announced that it has entered into a $15-million U.S. loan agreement with Oxford Finance LLC. Proceeds will be used to finance Protox's late stage drug development program for the treatment of Benign Prostate Hyperplasia (BPH). Protox Therapeutics Inc.
shares T.PRX are trading even at $0.54.
